Our Office

Formal Lectures

Formal Lectures

Dr. Maddahi has delivered countless lectures on the subject of heart-related conditions and treatments over the last 35 years. His many lectures have assisted aspiring medical students to better understand their field, heralding in a new generation of medical professionals. He has constantly strived to innovate and resolve complex physical situations related to his area of expertise.

Choose a period of time:

  • 2013

    1. Cardiac Imaging: PET/CT
      Conjoint Nuclear Medicine Seminar
      Pasadena, CA
      January 12, 2013
    2. PET Myocardial Perfusions: New Tendencies
      Nuclear Cardiology Course by IAEA
      Mexico City, Mexico
      January 16, 2013
    3. Cardiac PET: Main application
      Nuclear Cardiology Course by IAEA
      Mexico City, Mexico
      January 16, 2013
    4. Clinical Impract of PET Myocardial Blood Flow Quantification
      Nuclear Cardiology Course by IAEA
      Mexico City, Mexico
      January 17, 2013
    5. Physiologic Basis of Myocardial Perfusion SPECT and PET
      The 27th Annual Case Review with the Experts: Advances in Nuclear Cardiology and Cardiac CT
      Los Angeles, CA
      January 18, 2013
    6. Assessment of Myocardial Viability: Classic Cases
      The 27th Annual Case Review with the Experts: Advances in Nuclear Cardiology and Cardiac CT
      Los Angeles, CA
      January 18, 2013
    7. Battle of the experts SPECT and PET
      The 27th Annual Case Review with the Experts: Advances in Nuclear Cardiology and Cardiac CT
      Los Angeles, CA
      January 18, 2013
  • 2012

    1. Nuclear Cardiology: Quo Vadis?
      Verani Memorial Lecture at the Methodist DeBakey Heart & Vascular Center Grand Rounds, Houston, Texas; January 12, 2012
    2. Current Protocols for Myocardial Perfusion SPECT and PET and their Physiologic Basis
      The 26th Annual Case Review with the Experts: Advances in Nuclear Cardiology and Cardiac CT, Los Angeles, California; January 20, 2012
    3. Myocardial Perfusion/Fucntion SPECT and PET
      The 26th Annual Case Review with the Experts: Advances in Nuclear Cardiology and Cardiac CT, Los Angeles, California; January 20, 2012
    4. Assessment of Myocardial Viability: Case Illustrations
      The 26th Annual Case Review with the Experts: Advances in Nuclear Cardiology and Cardiac CT, Los Angeles, California; January 20, 2012
    5. SPECT/PET Face-Off: Battle of the Experts "Challenging Uknown Cases"
      The 26th Annual Case Review with the Experts: Advances in Nuclear Cardiology and Cardiac CT, Los Angeles, California; January 20, 2012
    6. F 18 Flupiridaz: Results of Phase I and Phase II Clinical Trial—Results with a New PET MPI Radiopharmaceutical
      The 26th Annual Case Review with the Experts: Advances in Nuclear Cardiology and Cardiac CT, Los Angeles, California; January 21, 2012
    7. New Developments in PET and SPECT
      The 26th Annual Case Review with the Experts: Advances in Nuclear Cardiology and Cardiac CT, Los Angeles, California; January 21, 2012
    8. PET Cardiac Imaging: Challenges and Opportunities
      Conjoint Nuclear Medicine Seminar and 64th Annual LARS Midwinter Conference, Pasadena, California; January 21, 2012
    9. Proper reporting in myocardial perfusion imaging
      2nd Annual Meeting of the Kuwait Society of Nuclear Medicine
      Kuwait City, Kuwait; March 5, 2012
    10. MPI F-18 radiotracers, Future?
      2nd Annual Meeting of the Kuwait Society of Nuclear Medicine
      Kuwait City, Kuwait; March 5, 2012
    11. Gated SPECT in CAD, SPECT/MRI & SPECT/CT in CAD, and PET in CAD
      2nd Annual Meeting of the Kuwait Society of Nuclear Medicine
      Kuwait City, Kuwait; March 5, 2012
    12. Cardiac Viability
      2nd Annual Meeting of the Kuwait Society of Nuclear Medicine
      Kuwait City, Kuwait; March 6, 2012
    13. Instrumental new trends in cardiac imaging
      2nd Annual Meeting of the Kuwait Society of Nuclear Medicine
      Kuwait City, Kuwait; March 6, 2012
    14. New Radionuclide Imaging Agents: 18-Flurpiridaz and MIBG
      The 34th Annual Recent Advances in Clinical Nuclear Cardiology and Cardiac CT: Featuring Case Review with the Experts, Washington D.C.; May 3, 2012
    15. Current Protocols for Myocardial Perfusion SPECT and PET and their Physiological Basis
      The 34th Annual Recent Advances in Clinical Nuclear Cardiology and Cardiac CT: Featuring Case Review with the Experts, Washington D.C.; May 3, 2012
    16. New and Emerging Radiotracers in Cardiovascular Molecular Imaging
      The The 59th Annual Meeting of the Society of Nuclear Medicine, Miami, FL;
      June 12, 2012
    17. F-18 Myocardial Perfusion Imaging: Where are we now?
      The 17th Annual Scientific Session of the American Society of Nuclear Cardiology, Baltimore, MD;
      September 8, 2012
    18. Imgaing with F-18 Flurpiridaz: Protocols and Lab Requirements
      The 17th Annual Scientific Session of the American Society of Nuclear Cardiology, Baltimore, MD;
      September 8, 2012
    19. PET Tracers: Characteristics and Availability
      The 17th Annual Scientific Session of the American Society of Nuclear Cardiology, Baltimore, MD;
      September 8, 2012
  • 2011

    1. Current Protocols for Myocardial Perfusion SPECT and PET and their Physiologic Basis
      The 25th Annual Case Review with the Experts: Advances in Nuclear Cardiology and Cardiac CT, Los Angeles, California; January 21, 2011
    2. Panel Discussion: Myocardial Perfusion/Function SPECT and PET
      The 25th Annual Case Review with the Experts: Advances in Nuclear Cardiology and Cardiac CT, Los Angeles, California; January 21, 2011
    3. Myocardial Viability: Comparison of SPECT, PET, MRI, and CT Methods
      The 25th Annual Case Review with the Experts: Advances in Nuclear Cardiology and Cardiac CT, Los Angeles, California; January 22, 2011
    4. Workshop VII: Assessment of Myocardial Viability: Case Illustrations
      The 25th Annual Case Review with the Experts: Advances in Nuclear Cardiology and Cardiac CT, Los Angeles, California; January 22, 2011
    5. Update on the New Myocardial Perfusion PET Agent, [F-18] Flurpiridaz
      Conjoint Nuclear Medicine Seminar and 63rd Annual LARS Midwinter Conference, Pasadena, California; February 13, 2011
    6. Present and Future of Cardiac = PET?, Your Lecture: Flurpiridaz: The Ideal Agent?
      The 32nd Annual High Country Nuclear Medicine Conference, Steamboat Springs, Colorado; March 12, 2011
    7. Nuclear Imaging: Recent Advances and Relation to CT and MRI in CAD Evaluation
      The 8th Annual Clinical Breakthroughs in Cardiology, Snowbird, Utah; March 18, 2011
    8. Cardiac PET and PET CT, Lecture: PET versus Other Viability Assessment Techniques: When to Use What
      The 60th Annual Scientific Session of The American College of Cardiology, New Orleans, Louisiana; April 3, 2011
    9. Current Protocols for Myocardial Perfusion SPECT and PET and Their Physiological Basis
      The 33rd Annual Recent Advances in Clinical Nuclear Cardiology and Cardiac CT: Featuring Case Review with the Experts, May 5, 2011, Washington, D.C.
    10. SPECT and PET Before Non-cardiac Imaging and After CABG and PCI: Case Illustrations
      The 33rd Annual Recent Advances in Clinical Nuclear Cardiology and Cardiac CT: Featuring Case Review with the Experts, May 5, 2011, Washington, D.C.
    11. Workshop V: Assessment of Myocardial Viability and Ischemia: Case Illustrations
      The 33rd Annual Recent Advances in Clinical Nuclear Cardiology and Cardiac CT: Featuring Case Review with the Experts, May 6, 2011, Washington, D.C.
    12. Flurpiridaz F 18: A New PET Perfusion Tracer and Likely Clinical Impact
      The 33rd Annual Recent Advances in Clinical Nuclear Cardiology and Cardiac CT: Featuring Case Review with the Experts, May 7, 2011, Washington, D.C.
    13. Attenuation Correction Session: Clinical impact of attenuation correction: Diagnosis
      The 10th International Congress of Nuclear Cardiology, Amsterdam, Netherlands; May 16, 2011
    14. Phase 2 safety and clinical comparison of flurpiridaz F 18 injection PET and SPECT myocardial perfusion imaging for diagnosis of coronary artery disease
      The 10th International Congress of Nuclear Cardiology, Amsterdam, Netherlands; May 17, 2011
    15. New and emerging nuclear imaging biomarkers Session: New perfusion agents The 10th International Congress of Nuclear Cardiology, Amsterdam, Netherlands; May 17, 2011
    16. Driving Concepts of Cardiovascular Nuclear Imaging in the Current Era and an Update on Cardiovascular Molecular Imaging 2011 - Part I
      The 58th Annual Meeting of the Society of Nuclear Medicine, San Antonio, Texas; June 4, 2011
    17. Read With the Experts: F-18 FDG PET/CT Imaging in Cardiovascular Disease—Myocardial Viability Imaging with PET/CT: Comparison to SPECT
      The 58th Annual Meeting of the Society of Nuclear Medicine, San Antonio, Texas; June 5, 2011
    18. Phase 2 clinical comparison of flurpiridaz F 18 injection PET and SPECT myocardial perfusion imaging for diagnosis of coronary artery disease
      The 58th Annual Meeting of the Society of Nuclear Medicine, San Antonio, Texas; June 5, 2011
    19. Unconventional Sources of Artifacts with the Use of Newer Gamma Cameras and New Image Acquisition Systems
      The 58th Annual Meeting of the Society of Nuclear Medicine, San Antonio, Texas; June 7, 2011
    20. Comparison of flurpiridaz F 18 PET injection and Tc-99m labeled SEPCT myocardial perfusion imaging for identifying severity and extent of stress induced myocardial ischemia in phase 2 clinical trials.
      The 58th Annual Meeting of the Society of Nuclear Medicine, San Antonio, Texas; June 7, 2011
    21. Prevention of Heart Attack and Stroke
      Andishgah—A Hub for Optimum Analysis and Solutions Health Research Unit Presents: Prevention of Common Diseases, Los Angeles, California; June 26, 2011
    22. F 18 Labeled PET Perfusion Tracers
      The 16th Annual Scientific Session of the American Society of Nuclear Cardiology, Denver, Colorado; September 9, 2011
    23. Evaluation of Absolute MBF at Rest and Stress with Flurpiridaz F 18 Injection PET in Normal Subjects and Patients with Coronary Artery Disease (CAD) and in Two Types of Scanners
      The 16th Annual Scientific Session of the American Society of Nuclear Cardiology, Denver, Colorado; September 10, 2011
    24. Flurpiridaz F 18 Injection Phase 2 Experience
      Lantheus Medical Imaging Investigators Meeting, Miami, Florida;
      September 23, 2011
  • 2010

    1. Nuclear Imaging: Recent Advances and Relation to CT and MRI in CAD Evaluation
      The 7th Annual Clinical Breakthroughs in Cardiology, Snow Bird; January 15, 2010
    2. Novel PET Probes for Myocardial Stress/Rest Perfusion Imaging
      The 29th Annual Symposium of the European School of Nuclear Medicine, Bad Hofgastein, Austria; January 17, 2010
    3. Current Protocols for Myocardial Perfusion SPECT and PET and their Physiologic Basis
      The 24th Annual Case Review with the Experts: Advances in Nuclear Cardiology and Cardiac CT, Los Angeles, California; January 29, 2010
    4. Assessment of Myocardial Viability: Case Illustrations
      The 24th Annual Case Review with the Experts: Advances in Nuclear Cardiology and Cardiac CT, Los Angeles, California; January 30, 2010
    5. Assessment of Myocardial Viability
      The 31st Annual High Country Nuclear Medicine Conference, Steamboat Springs, Colorado February 27, 2010
    6. Myocardial Viability: What is the Best Imaging Modality: CT
      The 59th Annual Scientific Session of The American College of Cardiology, March 15, 2010, Atlanta, Georgia
    7. Comparison of F-18 Labeled BMS747158 PET and Tc-99m Labeled SPECT Myocardial Perfusion Imaging for Detection and Evaluation of Coronary Artery Disease
      The 59th Annual Scientific Session of The American College of Cardiology, March 16, 2010, Atlanta, Georgia
    8. New Developments in PET/CT Imaging of Myocardial Perfusion and Comparison to SPECT
      2010 Conjoint Western Regional Society of Nuclear Medicine Meeting, March 27, 2010, Pasadena, California
    9. Current Protocol for Myocardial Perfusion SPECT and PET and Their Physiological Basis
      The 32nd Annual Recent Advances in Clinical Nuclear Cardiology and Cardiac CT: Featuring Case Review with the Experts, May 6, 2010, Washington, D.C.
    10. Workshop VI: Assessment of Myocardial Viability and Ischemia: Case Illustrations
      The 32nd Annual Recent Advances in Clinical Nuclear Cardiology and Cardiac CT: Featuring Case Review with the Experts, May 7, 2010, Washington, D.C.
    11. Future of Nuclear Cardiology: Long Awaited Changes
      The 32nd Annual Recent Advances in Clinical Nuclear Cardiology and Cardiac CT: Featuring Case Review with the Experts, May 7, 2010, Washington, D.C.
    12. Role of SPECT, PET, or Echocardiography in the Assessment of Myocardial Viability
      The 57th Annual Meeting of the Society of Nuclear Medicine, Salt Lake City, Utah, June 6, 2010
    13. Current and Future Radiopharmaceuticals for Cardiac Imaging
      The 57th Annual Meeting of the Society of Nuclear Medicine, Salt Lake City, Utah, June 7, 2010
    14. Novel Radiopharmaceuticals - Can they prevent Nuclear Imaging from becoming extinct?
      The 57th Annual Meeting of the Society of Nuclear Medicine, Salt Lake City, Utah, June 7, 2010
    15. F-18 labeled BMS747158 PET myocardial perfusion imaging identifies more severe and extensive stress induced myocardial ischemia than Tc-99m Sestamibi SPECT
      The 57th Annual Meeting of the Society of Nuclear Medicine, Salt Lake City, Utah, June 8, 2010
    16. New Designs in PET Instrumentation
      2010 Viva Las Vegas Pacific Southwest Technologist Chapter of the Society of Nuclear Medicine, Las Vegas, Nevada, July 18, 2010
    17. New Radiopharmaceuticals and Protocols in MPI
      2010 Viva Las Vegas Pacific Southwest Technologist Chapter of the Society of Nuclear Medicine, Las Vegas, Nevada, July 18, 2010
    18. SPECT/PET Approach
      The 15th Annual Scientific Session of the American Society of Nuclear Cardiology, Philadelphia, Pennsylvania, September 23, 2010
    19. Properties of Ideal PET Perfusion Tracer; New PET Agent Cases and Data
      The 15th Annual Scientific Session of the American Society of Nuclear Cardiology, Philadelphia, Pennsylvania, September 24, 2010
    20. Advances in Perfusion Imaging
      The 15th Annual Scientific Session of the American Society of Nuclear Cardiology, Philadelphia, Pennsylvania, September 24, 2010
    21. How to Assess Heart Failure with PET: Perfusion, Function, and Metabolism
      The 15th Annual Scientific Session of the American Society of Nuclear Cardiology, Philadelphia, Pennsylvania, September 24, 2010
    22. Preliminary Results of Absolute Quantification of Rest and Stress Myocardial Blood Flow with Flurpiridaz F-18 PET in Normal and Coronary Artery Disease Patients in a Single-Center Study
      The 15th Annual Scientific Session of the American Society of Nuclear Cardiology, Philadelphia, Pennsylvania, September 25, 2010
    23. Interpretation of Gated SPECT - Nuances of New Software and New Cameras
      The 15th Annual Scientific Session of the American Society of Nuclear Cardiology, Philadelphia, Pennsylvania, September 25, 2010
    24. New Perfusion Agents - Can We Do Better?
      The 15th Annual Scientific Session of the American Society of Nuclear Cardiology, Philadelphia, Pennsylvania, September 25, 2010
    25. Excitement for the future of PET MPI
      The 15th Annual Scientific Session of the American Society of Nuclear Cardiology, Philadelphia, Pennsylvania, September 25, 2010
    26. Present and Future of Nuclear Cardiology
      The 35th Annual Meeting of the Western Regional Society of Nuclear Medicine, Garden Grove, California, October 23, 2010

Call 310-824-4991 or Click Here to Schedule Your Cardiac Consultation.